Clinical Trial Update: Study of Erythropoietin (EPO) Administration Schedule [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the schedule of erythropoietin administration in patients with chronic kidney disease and anemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Chronic Renal Failure, Anaemia | Phase 4 | Status: COMPLETED